Literature DB >> 25621151

Right ventricle in acute and chronic pulmonary embolism (2013 Grover Conference series).

Christian Gerges1, Nika Skoro-Sajer1, Irene M Lang1.   

Abstract

Venous thromboembolism (VTE) encompasses deep-vein thrombosis and pulmonary embolism (PE). It is the third-most-frequent cardiovascular disease, with an overall annual incidence of 1-2 per 1,000 population. Chronic thromboembolic pulmonary hypertension (CTEPH) is regarded as a late sequela of PE, with a reported incidence varying between 0.1% and 9.1% of those surviving acute VTE. Right ventricular (RV) function is dependent on afterload. The most precise technique to describe RV function is invasive assessment of the RV-to-pulmonary vascular coupling. However, assessments of RV afterload (i.e., steady and pulsatile flow components and their product, the RC-time) may be useful hemodynamic surrogates of coupling. RV load is different in acute and chronic PE. In acute PE, more than 60% occlusion of the cross-sectional area of the pulmonary artery within a short period of time leads to abrupt hemodynamic collapse. If the time of occlusion is limited to ∼15 seconds, significant decreases in fractional area change, tricuspid annulus systolic excursion, and RV free-wall deformation (strain) occur, with the latter showing significant postsystolic shortening. These changes have similarities to ischemic stunning, and they recover within minutes. In CTEPH, studies of pulmonary vascular resistance (PVR) and pulmonary arterial compliance demonstrated low RC-times that were further lowered after pulmonary endarterectomy (PEA). Immediate postoperative PVR was the only predictor of long-term survival/freedom from lung transplantation, suggesting that the effect of PEA on opening vascular territories to flow outweighs its effect on proximal stiffness. This review summarizes the current knowledge on vascular and intrinsic RV adaptation to VTE, including CTEPH, and the role of imaging.

Entities:  

Keywords:  hemodynamics; pulmonary embolism; pulmonary heart disease; right ventricle

Year:  2014        PMID: 25621151      PMCID: PMC4278597          DOI: 10.1086/676748

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  90 in total

1.  Assessment of acute respiratory failure: cardiac versus pulmonary causes.

Authors:  P M Stevens
Journal:  Chest       Date:  1975-01       Impact factor: 9.410

Review 2.  Chronic major-vessel thromboembolic pulmonary hypertension.

Authors:  K M Moser; W R Auger; P F Fedullo
Journal:  Circulation       Date:  1990-06       Impact factor: 29.690

3.  Hemodynamic determinants of the time-course of fall in canine left ventricular pressure.

Authors:  J L Weiss; J W Frederiksen; M L Weisfeldt
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

Review 4.  Hemodynamic monitoring: invasive techniques.

Authors:  N Buchbinder; W Ganz
Journal:  Anesthesiology       Date:  1976-08       Impact factor: 7.892

5.  Decreased time constant of the pulmonary circulation in chronic thromboembolic pulmonary hypertension.

Authors:  Robert V MacKenzie Ross; Mark R Toshner; Elaine Soon; Robert Naeije; Joanna Pepke-Zaba
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-17       Impact factor: 4.733

6.  Value of a Doppler-derived index combining systolic and diastolic time intervals in predicting outcome in primary pulmonary hypertension.

Authors:  T C Yeo; K S Dujardin; C Tei; D W Mahoney; M D McGoon; J B Seward
Journal:  Am J Cardiol       Date:  1998-05-01       Impact factor: 2.778

7.  The hemodynamic response to pulmonary embolism in patients without prior cardiopulmonary disease.

Authors:  K M McIntyre; A A Sasahara
Journal:  Am J Cardiol       Date:  1971-09       Impact factor: 2.778

8.  Validation of myocardial acceleration during isovolumic contraction as a novel noninvasive index of right ventricular contractility: comparison with ventricular pressure-volume relations in an animal model.

Authors:  Michael Vogel; Michael R Schmidt; Steen B Kristiansen; Michael Cheung; Paul A White; Keld Sorensen; Andrew N Redington
Journal:  Circulation       Date:  2002-04-09       Impact factor: 29.690

9.  Active search for chronic thromboembolic pulmonary hypertension does not appear indicated after acute pulmonary embolism.

Authors:  Sulaiman Surie; Nadine S Gibson; Victor E A Gerdes; Berto J Bouma; Berthe L F van Eck-Smit; Harry R Buller; Paul Bresser
Journal:  Thromb Res       Date:  2010-01-20       Impact factor: 3.944

Review 10.  Technique and outcomes of pulmonary endarterectomy surgery.

Authors:  Patricia A Thistlethwaite; Kan Kaneko; Michael M Madani; Stuart W Jamieson
Journal:  Ann Thorac Cardiovasc Surg       Date:  2008-10       Impact factor: 1.520

View more
  9 in total

Review 1.  Interventional Therapy for Pulmonary Embolism.

Authors:  Alan B Lumsden; Erik Suarez
Journal:  Methodist Debakey Cardiovasc J       Date:  2016 Oct-Dec

2.  The role of tissue factor and autophagy in pulmonary vascular remodeling in a rat model for chronic thromboembolic pulmonary hypertension.

Authors:  Chaosheng Deng; Dawen Wu; Minxia Yang; Yunfei Chen; Haibo Ding; Zhanghua Zhong; Ningfang Lian; Qiaoxian Zhang; Shuang Wu; Kaixiong Liu
Journal:  Respir Res       Date:  2016-05-27

3.  Saddle pulmonary embolism: right ventricular strain an indicator for early surgical approach.

Authors:  Vinod Namana; Sabah Siddiqui; Ram Balasubramanian; Rajeswer Sarasam; Vijay Shetty
Journal:  Oxf Med Case Reports       Date:  2016-06-01

4.  Prostacyclins have no direct inotropic effect on isolated atrial strips from the normal and pressure-overloaded human right heart.

Authors:  Sarah Holmboe; Asger Andersen; Rebekka V Jensen; Hans Henrik Kimose; Lars B Ilkjær; Lei Shen; Lucie H Clapp; Jens Erik Nielsen-Kudsk
Journal:  Pulm Circ       Date:  2017-05-30       Impact factor: 3.017

5.  Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension.

Authors:  Yoshihiro Kamimura; Naoki Okumura; Shiro Adachi; Shigetake Shimokata; Fumitaka Tajima; Yoshihisa Nakano; Akihiro Hirashiki; Toyoaki Murohara; Takahisa Kondo
Journal:  Heart Vessels       Date:  2018-04-27       Impact factor: 2.037

Review 6.  Management of High-Risk Pulmonary Embolism: What Is the Place of Extracorporeal Membrane Oxygenation?

Authors:  Benjamin Assouline; Marie Assouline-Reinmann; Raphaël Giraud; David Levy; Ouriel Saura; Karim Bendjelid; Alain Combes; Matthieu Schmidt
Journal:  J Clin Med       Date:  2022-08-13       Impact factor: 4.964

7.  LncRNA GAS5 promotes spermidine‑induced autophagy through the miRNA‑31‑5p/NAT8L axis in pulmonary artery endothelial cells of patients with CTEPH.

Authors:  Qinghua Wu; Xiaohui Zhou; Yan Wang; Yamin Hu
Journal:  Mol Med Rep       Date:  2022-08-03       Impact factor: 3.423

8.  Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension.

Authors:  Manuel Jonas Richter; Katrin Milger; Khodr Tello; Philipp Stille; Werner Seeger; Eckhard Mayer; Hossein A Ghofrani; Henning Gall
Journal:  BMC Pulm Med       Date:  2016-07-04       Impact factor: 3.317

9.  Double Bolus Alteplase Therapy during Cardiopulmonary Resuscitation for Cardiac Arrest due to Massive Pulmonary Embolism Guided by Focused Bedside Echocardiography.

Authors:  Hafiz B Mahboob; Bruce W Denney
Journal:  Case Rep Crit Care       Date:  2018-03-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.